Skip to main content
HairCited

Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series.

Ji Won Lee, Da-Ae Yu, Soyun Cho, Sang Woong Youn, Ohsang Kwon
Other The Journal of dermatology 2023 3 citazioni
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D36651019'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Tipo di studio
Review
Dimensione del campione
4
Popolazione
Dress from 2009 to 2021
Durata
26.0 weeks
Intervento
Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series. 60%
Comparatore
None
Esito primario
hair growth/density
Direzione dell'effetto
Positive
Rischio di bias
Unclear

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous drug adverse reaction characterized by various cutaneous and systemic manifestations. However, reports on the various patterns of alopecia after DRESS are lacking. Thus, we aimed to describe cases of alopecia after DRESS and review the literature. This multicentric retrospective study reviewed the records of 182 patients diagnosed with DRESS from 2009 to 2021; of these, 10 who had alopecia after DRESS were included. Patients were diagnosed with permanent alopecia (n = 4), telogen effluvium (n = 5), and alopecia areata (n = 1), and were treated with topical minoxidil or alfatradiol (6; 60%), topical corticosteroids (3; 30%), dietary supplements (6; 60%), systemic corticosteroids (1; 10%), and intralesional corticosteroid injection (2; 20%). Although patients with permanent alopecia did not show hair regrowth after 6 months, those with telogen effluvium and alopecia areata experienced marked clinical improvement within 6 months. Various types of alopecia can persist over an extended period, even after the resolution of an acute episode of DRESS.

TL;DR

Although patients with permanent alopecia did not show hair regrowth after 6 months, those with telogen effluvium and alopECia areata experienced marked clinical improvement within 6 months.

Used In Evidence Reviews

Similar Papers